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A series of antibacterial and antifungal amino acid-derived compounds and their cobalt(II), copper(II), nickel(II), and zinc(II)
metal complexes have been synthesized and characterized by their elemental analyses, molar conductances, magnetic moments,
andIR,andelectronicspectralmeasurements.Ligands(L1)–(L5)werederivedbycondensationofβ-diketoneswithglycine,pheny-
lalanine, valine, and histidine and act as bidentate towards metal ions (cobalt, copper, nickel, and zinc) via the azomethine-N
and deprotonated-O of the respective amino acid. The stoichiometric reaction between the metal(II) ion and synthesized lig-
ands in molar ratio of M : L (1 : 1) resulted in the formation of the metal complexes of type [M(L)(H2O)4]Cl (where M =
Co(II), Cu(II), and Zn(II)) and of M : L (1 : 2) of type [M(L)2(H2O)2]( w h e r eM= Co(II), Cu(II), Ni(II), and Zn(II)). The
magnetic moment data suggested for the complexes to have an octahedral geometry around the central metal atom. The elec-
tronic spectral data also supported the same octahedral geometry of the complexes. Elemental analyses and NMR spectral data
of the ligands and their metal(II) complexes agree with their proposed structures. The synthesized ligands, along with their
metal(II) complexes, were screened for their in vitro antibacterial activity against four Gram-negative (Escherichia coli, Shigella
ﬂexeneri, Pseudomonas aeruginosa, and Salmonella typhi) and two Gram-positive (Bacillus subtilis and Staphylococcus aureus)b a c -
terial strains and for in vitro antifungal activity against Trichophyton longifusus, Candida albicans, Aspergillus ﬂavus, Microsporum
canis, Fusarium solani, and Candida glaberata. The results of these studies show the metal(II) complexes to be more antibacte-
rial/antifungal against one or more species as compared to the uncomplexed ligands. The brine shrimp bioassay was also carried
out to study their in vitro cytotoxic properties. Five compounds, (3), (7), (10), (11), and (22), displayed potent cytotoxic ac-
tivity as LD50 = 8.974 × 10
−4,7.022 × 10
−4,8.839 × 10
−4,7.133 × 10
−4, and 9.725 × 10
−4 M/mL, respectively, against Artemia
salina.
Copyright © 2006 Zahid H. Chohan et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
We have already drawn attention [1–5] to the strong rela-
tionship between metals or their complexes, and antibac-
terial [6–12], antitumour [13–15], and anticancer [16, 17]
activities. A number of in vivo studies have indicated [18–
20] that biologically active compounds become more bacte-
riostatic and carcinostatic upon chelation. Such interaction
of transition-metal ions with amino acids and peptides is
of immense biological importance [21–23]. It has been re-
ported [24–28] that metal complexes of amino acid Schiﬀ
bases with transition metals possess anticarcinogenic activ-
ity. Various tumors tend to have poor blood supplies, and
therefore amino acids have been eﬀectively used to direct ni-
trogen mustards into the cancer cells. For example, pheny-
lalanine mustard is used in controlling malignant myeloma
[29]a n dB u r k e t t ’ sl y m p h o m a[ 30], and similarly sarcolysine
[31] is used to treat wide range of tumors. Indeed, certain
tumors and cancer cells are unable to produce all the amino
acids synthesized by the normal cells. Therefore, these cells
require an external supply of such essential amino acids to
pass on to the cancer cells by the blood stream. In the recent
past, a number of studies have highlighted the use of acety-
lacetone in various signiﬁcant applications [32–37]. In the2 Bioinorganic Chemistry and Applications
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Figure 1: Proposed structure of the ligands (L1)–(L5).
present studies, ligands (L1)–(L5)( Figure 1) were obtained
by the condensation reaction between amino acids (glycine,
phenylalanine, alanine, valine, or histidine) and acetylace-
tone with this hope that it may provide us valuable theo-
retical information for exploring metal-based bacteriostatic
and/or carcinostatic pharmaceuticals with high eﬃcacy and
lowtoxicity.Inthiseﬀort,wehavealsointroducedanazome-
thine (−C=N) linkage with the concern that it may permit a
notable variety in the remarkable chemistry and behavior of
such compounds. The synthesized amino acid-derived com-
pounds (L1)–(L5) have been exposed to act as bidentate to-
wardsdivalentmetalatomssolelythroughtheazomethine-N
andcarboxylatogroupsformingastable5-memberedchelate
ring system. The metal(II) complexes, (1)–(40) of the types
[M(L)(H2O)4] and [M(L)2(H2O)2]Cl (where M = Co(II),
Cu(II), Ni(II), and Zn(II) and L = amino acid-derived lig-
ands (L1)–(L5)) were formed by a stoichiometric ratio of M :
La s( 1:2 )a n d( 1:1 ) ,r e s p e c t i v e l y .T h e s et w od i ﬀerent sto-
ichiometric ratios of the ligand incorporated with the metal
ion were used in order to study the eﬀect of the presence of
one or two ligands, respectively, on the biological activity. All
these compounds have been characterized by their IR, NMR,
molar conductance, magnetic moment, and elemental anal-
yses. The IR of the ligands and their corresponding metal(II)
complexes are in agreement with the proposed structures.
The magnetic moment and electronic spectral data suggest
for all the complexes to have an octahedral geometry. Ele-
mental analyses and NMR spectral data of the ligands and
their metal(II) complexes also agree with the structures as
anticipated. All these ligands along with their metal(II) com-
plexes were screened for their in vitro antibacterial activity
against four Gram-negative (E coli, S ﬂexenari, P aeruginosa,
and S typhi) and two Gram-positive (Bs u b t i l i sand Sa u r e u s )
bacterial strains and for in vitro antifungal activity against
T longifusus, C albicans, A ﬂavus, M canis, F solani, and C
glaberata. These compounds have shown varied antibacterial
and antifungal activities against one or more bacterial/fungal
strainsandthisactivityenhancedoncoordination/chelation.
The reported compounds are not only good candidates as
antibacterial and antifungal agents, but also are a promis-
ing addition of new class of compounds as the metal-based
drugs.
EXPERIMENTAL
Materialandmethods
Solvents used were analytical grades; all metal(II) were used
as chloride salts. IR spectra were recorded on the Philips
Analytical PU 9800 FTIR spectrophotometer. NMR spec-
tra were recorded on Perkin-Elmer 283B spectrometer. UV-
visible spectra were obtained in DMF on a Hitachi U-2000
double-beam spectrophotometer. C, H, and N analyses, con-
ductance and magnetic measurements were carried out on
solid compounds using the respective instruments. Melting
points were recorded on a Gallenkamp apparatus and are
not corrected. The complexes were analyzed for their metal
contents by EDTA titration [38]. Antibacterial and antifun-
gal screening was done at HEJ Research Institute of Chem-
istry, International Center for Chemical Sciences, University
of Karachi, Pakistan.
PreparationofSchiff-bases(L1)–(L5)
Acetylacetone (20mmol) in ethanol (10mL) was added to
a stirred solution of the amino acid (20mmol) in water
(30mL). The mixture was reﬂuxed for 4–6 hours during
which the color of the solution turned to yellow-orange. The
completion of reaction was monitored through TLC. After
completion of the reaction, it was cooled to aﬀord a solid
product. The solid residue was ﬁltered, washed with ethanol,
then with ether, and dried. Crystallization from a mixture of
ethanol-propanol (60 : 40) aﬀorded the desired ligands. The
same method was applied for the preparation of all other lig-
ands by using the corresponding amino acids and/or acety-
lacetone, working in the same conditions with their respec-
tive molar ratio.
{[(3-Hydroxy-1-methylbutyl)-2-en-1-ylidene]
amino}aceticacid(L1)
Yield 52%; mp 294◦C; IR (KBr, cm−1): 3444 (OH), 3015
(C=C), 1700 (COOH), 1635 (azomethine, HC=N); 1H
NMR (DMSO-d6, δ, ppm): 1.85 (s, 6H, CH3), 2.83 (t, 2H,
CH2), 5.18 (t, 1H, CH), 6.94 (s, 1H, azomethine), 10.27 (s,
1H, OH), 11.29 (s, 1H, COOH). Anal. Calcd. for C7H11NO3
(157.0 ) :C ,5 3 .50; H, 7.01; N, 8.92. Found: C, 53.32; H, 7.41;
N, 8.86%. 1H NMR of Zn(II) complex (DMSO-d6, δ, ppm):
2.08 (s, 6H, CH3), 2.98 (t, 2H, CH2), 5.37 (t, 1H, CH), 7.48
(s, 1H, azomethine), 10.58 (s, 1H, OH), 11.36 (s, 4H, OH2).
{[2-(3-Hydroxy-1-methylbutyl)-2-en-1-ylidene]amino}-
3-phenylpropanoicacid(L2)
Yield 56%; mp 242◦C; IR (KBr, cm−1): 3444 (OH), 3049
(C=C), 1703 (COOH), 1635 (azomethine, C=N); 1HN M R
(DMSO-d6, δ, ppm): 1H NMR (DMSO-d6, δ, ppm): 1.75
(s, 6H, CH3), 2.53 (t, 2H, CH2), 3.18 (t, 1H, CH2), 3.73
(t, 2H, CH2), 6.67 (s, 1H, azomethine), 7.16–7.79 (m, 5H,
Ph), 10.27 (s, 1H, OH), 11.29 (s, 1H, COOH). Anal. Calcd.
for C14H19NO2 (233.0): C, 68.02; H, 6.88; N, 5.67. Found:
C, 68.33; H, 7.15; N, 5.83%. 1H NMR of Zn(II) complexZahid H. Chohan et al 3
(DMSO-d6, δ, ppm): 1.97 (s, 6H, CH3), 2.86 (t, 2H, CH2),
3.41 (t, 1H, CH2), 3.96 (t, 2H, CH2), 7.51 (s, 1H, azome-
thine), 7.36–7.93 (m, 5H, Ph), 10.58 (s, 1H, OH), 11.36 (s,
4H, OH2).
{[2-(3-Hydroxy-1-methylbutyl)-2-en-1-ylidene]amino}-
3-methylbutanoicacid(L3)
Yield 54%; mp 210◦C; IR (KBr, cm−1): 3444 (OH), 3049
(C=C), 1708 (COOH), 1635 (azomethine, C=N); 1HN M R
(DMSO-d6, δ, ppm): 1.88 (s, 12H, CH3), 3.16 (t, 1H, CH),
3.73 (t, 1H, CH), 5.52 (t, 1H, CH), 10.27 (s, 1H, OH),
11.29 (s, 1H, COOH). Anal. Calcd. for C10H17NO3 (199.0):
C, 60.30; H, 8.54; N, 7.04. Found: C, 60.64; H, 8.37; N,
7.46%. 1H NMR of Zn(II) complex (DMSO-d6, δ, ppm):
2.03 (s, 12H, CH3), 3.37 (t, 1H, CH), 3.96 (t, 1H, CH), 5.87
(t, 1H, CH), 10.56 (s, 1H, OH), 11.36 (s, 4H, OH2).
{[2-(3-Hydroxy-1-methylbutyl)-2-en-1-ylidene]amino}-
3-(imidazol-4-yl)propanoicacid(L4)
Yield 51%; mp 194◦C; IR (KBr, cm−1): 3444 (OH), 3045
(C=C), 1705 (COOH), 1635 (azomethine, C=N); 1HN M R
(DMSO-d6, δ, ppm): 1H NMR (DMSO-d6, δ, ppm): 1.75
(s, 6H, CH3), 3.36 (t, 1H, CH), 3.78 (s, 1H, CH), 7.96 (s,
1H, imidazol), 8.26 (d, 1H, imidazol), 10.27 (s, 1H, OH),
10.84 (s, 1H, NH), 11.29 (s, 1H, COOH). Anal. Calcd. for
C10H13N3O3 (223.0): C, 55.23; H, 7.11; N, 17.53. Found:
C, 55.53; H, 7.38; N, 17.26%; 1H NMR of Zn(II) complex
(DMSO-d6, δ, ppm): 2.07 (s, 6H, CH3), 3.58 (t, 1H, CH),
3.94 (s, 1H, CH), 8.25 (s, 1H, imidazol), 8.47 (dd, 1H, imi-
dazol), 10.58 (s, 1H, OH), 11.13 (s, 1H, NH), 11.36 (s, 4H,
OH2).
{[2-(3-Hydroxy-1-methylbutyl)-2-en-1-
ylidene]amino}propanoicacid(L5)
Yield 53%; mp 160◦C; IR (KBr, cm−1): 3444 (OH), 3018
(C=C), 1700 (COOH), 1635 (azomethine, C=N); 1HN M R
(DMSO-d6, δ, ppm): 1.85 (s, 9H, CH3), 5.18 (t, 1H, CH),
5.34 (t, 1H, CH), 10.27 (s, 1H, OH), 11.29 (s, 1H, COOH).
Anal. Calcd. for C8H13NO3 (171.0): C, 47.76; H, 7.46; N,
20.90. Found: C, 47.57; H, 7.28; N, 20.77%. 1HN M Ro f
Zn(II) complex (DMSO-d6, δ, ppm): 2.12 (s, 9H, CH3), 5.41
(t, 1H, CH), 5.63 (t, 1H, CH), 10.58 (s, 1H, OH), 11.36 (s,
4H, OH2).
Preparationofmetal(II)complexes
For the preparation of metal(II) complexes, a solution
(30mL) of the corresponding ligand in hot methanol was
added to a stirred solution of metal(II) chloride in ethanol
(25mL) having a required molar ratio of M : L (1 : 1 and
1 : 2). The mixture was reﬂuxed for 3 hours and then cooled
to room temperature which solidiﬁed on cooling. The solid
thus obtained was ﬁltered, washed with methanol/ethanol
and ether, and ﬁnally dried in air to aﬀord the desired prod-
uct. Crystallization from aqueous/ethanol (40 : 60) gave the
expected metal complex.
BIOLOGICAL ACTIVITY
Antibacterialbioassay(invitro)
All the synthesized ligands (L1)–(L5) and their correspond-
ing metal(II) complexes (1)–(20) were screened in vitro for
theirantibacterialactivityagainstfourGram-negative(Ecoli,
S ﬂexenari, P aeruginosa, and S typhi) and two Gram-positive
(Bs u b t i l i sand Sa u r e u s ) bacterial strains using agar-well dif-
fusion method [39]. Two to eight hours old bacterial in-
oculums containing approximately 104–106 colony forming
units (CFU)/mL were used in these assays. The wells were
dug in the media with the help of a sterile metallic borer
with centers at least 24mm. Recommended concentration
(100μl) of the test sample (1mg/mL in DMSO) was intro-
duced in the respective wells. Other wells supplemented with
DMSO and reference antibacterial drug, imipenum served as
negative and positive controls, respectively. The plates were
incubated immediately at37◦C for 20 hours. Activity wasde-
termined by measuring the diameter of zones showing com-
pleteinhibition(mm).Growthinhibitionwascompared[40]
with the standard drug. In order to clarify any participating
role of DMSO in the biological screening, separate studies
were carried out with the solutions alone of DMSO and they
showed no activity against any bacterial strains.
Antifungalactivity(invitro)
Antifungal activities of all compounds were studied against
six fungal cultures, T longifusus, C albicans, A ﬂavus, M canis,
Fs o l a n i ,a n dCg l a b e r a t a . Sabouraud dextrose agar (Oxoid,
Hampshire,England)wasseededwith105 (cfu) mL−1 fungal
spore suspensions and was transferred to petri plates. Discs
soaked in 20mL (10μg/mL in DMSO) of all compounds
were placed at diﬀerent positions on the agar surface. The
plateswereincubatedat32◦Cforsevendays.Theresultswere
recorded as zones of inhibition in mm and were compared
with standard drugs Miconazole and Amphotericin B.
Minimuminhibitoryconcentration(MIC)
Compounds containing antibacterial activity over 80% were
selected for minimum inhibitory concentration (MIC) stud-
ies (Table 5). The minimum inhibitory concentration was
determined using the disc diﬀusion technique [39]b yp r e -
paringdiscscontaining10,25,50,and100μg/mLofthecom-
pounds and applying the protocol.
Cytotoxicity(invitro)
Brine shrimp (Artemia salina leach) eggs were hatched in a
shallow rectangular plastic dish (22×32cm), ﬁlled with arti-
ﬁcialseawater,whichwasprepared[24]withcommercialsalt
mixture and double distilled water. An unequal partition was
made in the plastic dish with the help of a perforated device.
Approximately 50mg of eggs were sprinkled into the large
compartment, which was darkened while the matter com-
partment was opened to ordinary light. After two days, nau-
pliiwerecollectedbyapipettefromthelightedside.Asample4 Bioinorganic Chemistry and Applications
of the test compound was prepared by dissolving 20mg of
each compound in 2mL of DMF. From this stock solutions,
500, 50, and 5μg/mL were transferred to 9 vials (three for
each dilution were used for each test sample and LD50 is the
mean of three values) and one vial was kept as control hav-
ing 2mL of DMF only. The solvent was allowed to evaporate
overnight. After two days, when shrimp larvae were ready,
1mL of seawater and 10 shrimps were added to each vial (30
shrimps/dilution) and the volume was adjusted with seawa-
t e rt o5m Lp e rv i a l .A f t e r2 4h o u r s ,t h en u m b e r so fs u rv i v o r s
were counted. Data were analyzed by Finney computer pro-
gram to determine the LD50 values [41].
RESULT AND DISCUSSION
Physicochemicalpropertiesofobtainedcompounds
The ligands (L1)–(L5) were prepared by reﬂuxing an appro-
priate amount of respective amino acid with the correspond-
ing acetylacetone in ethanol. The structures of the synthe-
sizedligandswereestablishedwiththehelpoftheirIR,NMR,
and microanalytical data. All metal(II) complexes (1)–(40)
of these ligands were prepared by using the respective metal
salts as chloride with the corresponding ligands in two dif-
ferent molar ratios of metal : ligand as 1 : 2 and 1 : 1.
All these complexes are intensively colored air and moisture
stable amorphous solids which decompose without melting.
They are insoluble in common organic solvents and only sol-
uble in water, DMF, and DMSO. Molar conductance values
of the soluble complexes in DMF (10−3 Ms o l u t i o na t2 5 ◦C)
indicated that complexes having molar ratio of metal : ligand
as 1 : 2 have lower values (26–35Ohm−1 cm−2 mol−1) in-
dicating that they are all nonelectrolytic in nature. How-
ever, the complexes having molar ratio of metal : ligand as
1 : 1 showed higher values (122–128Ohm−1 cm−2 mol−1)
indicating them as electrolytic [42]. The elemental analy-
ses data (Table 1) agree well with the proposed formulae
for the ligands and also conﬁrmed the [M(L)2(OH2)2]
(Figure 2(a)) and [M(L)(OH2)4]Cl (Figure 2(b)) composi-
tion of the metal(II) chelates. Eﬀorts to grow good crystals
of the ligands and their metal chelates for X-ray diﬀraction
studieswereunsuccessfulduetotheirpoorsolubilityincom-
mon organic solvents.
IRspectra
Diketones and related compounds such as acetylacetone
in the present studies are capable of exhibiting keto-enol
tautomerism and react with metal cations to form metal
complexes. The selected IR spectra of the ligands and its
metal(II) complexes along with their tentative assignments
are reported in “experimental” and in Table 2,r e s p e c t i v e l y .
The IR spectra of all the ligands show [43] the absence of
bands at 3245 and 1745cm−1 due to ν(HN2) group of amino
acids and ν(C=O) of acetylacetone. Instead, a new promi-
nent band at 1635cm−1 due to azomethine ν(C=N) linkage
appeared in all the ligands indicating [44] that condensation
between ketone moiety of acetylacetone and that of amino
group of amino acid has taken place resulting into the for-
mation of the desired ligands (L1)–(L5). Also, the presence of
bandsat3015–3025and3444–3450cm−1 duetoν(C=C)and
ν(OH) in the ligands clearly gave an evidence [43]o fe s t a b -
lishing keto-enol tautomeric system in which these ligands
behave as enol. Moreover, on comparison of the IR spectra
of the ligands with their metal(II) complexes showed [45]a
major shift to lower wave numbers by 15–20cm−1 in azome-
thine ν(C=N) at 1610–1620cm−1 suggesting involvement of
the azomethine-N with the metal(II) ion. Also, disappear-
ance of the stretching frequency at 1700–1708cm−1 assigned
to ν( C O O H )a n da p p e a r a n c eo fn e wνas and νs modes of
the (−CO2) group at 1590 and 1385cm−1, respectively, the
Δν value (205cm−1) is consistent with carboxylate coordina-
tion with the metal atoms. These overall data suggest that the
azomethine-N and carboxylate-O groups are involved in co-
ordination with the metal(II) ion in complexes (1)–(40). In
the low-frequency region, spectra of the metal(II) complexes
(Table 1) exhibited [46] new bands which are not present in
the spectra of the ligands. These bands are located at 525 and
470cm−1, which are attributed to ν(M−O) and ν(M−N).
Thecoordinatedwaterinallthemetal(II)complexespresents
diﬀerent peaks at 990cm−1 (rocking) and 760cm−1 (wag-
ging), whereas none of these vibrations appear in the spectra
of uncoordinated ligands.
NMRspectra
The 1H NMR spectral data are reported along with the pos-
sible assignments in “experimental.” All the protons were
found as to be in their expected region [47]. The conclu-
sions drawn from these studies lend further support to the
mode of bonding discussed in their IR spectra. In the spec-
tra of diamagnetic Zn(II) complexes, coordination of the lig-
andsviaazomethine-Nandcarboxylate-Owasestablishedby
downﬁeld shifting of these signals in the Zn(II) complexes
due to the increased conjugation and coordination [48]. The
number of protons calculated from the integration curves
and those obtained from the values of the expected CHN
analyses agree with each other. It was observed that DMSO
did not have any coordinating eﬀect neither on the spectra of
the ligands nor on its metal complexes.
Electronicspectra
The Co(II) complexes exhibited well-resolved bands at
17543–18018cm−1 and a strong high-energy band at 21739–
22222cm−1 (Table 2) and are assigned [49] to the transi-
tions 4T1g(F)→4T2g(F), 4T1g(F)→4T1g(P) for a high-spin oc-
tahedral geometry [50]. A high-intensity band at 28565–
29215cm−1 was assigned to the metal to ligand charge trans-
fer. The magnetic susceptibility measurements (4.7–4.9BM)
for the solid Co(II) complexes are also indicative of three
unpaired electrons per Co(II) ion suggesting [51] consis-
tency with their octahedral environment. The electronic
spectra of the Cu(II) complexes (Table 2) showed two low-
energy weak bands at 15151–15873cm−1 and a strong high-
energy band at 30255–30420cm−1. The low-energy band inZahid H. Chohan et al 5
Table 1: Physical and analytical data of the metal(II) complexes (1)–(40).
Number Metal chelate MP (◦C) Yield (%) Calc (found) %
CHN
(1) [Co(L1)2(H2O)2] [406.9] 336–338 71 41.28 (41.61) 5.90 (5.42) 6.88 (6.13)
C14H24CoN2O8
(2) [Cu(L1)2(H2O)2] [411.5] 328–330 73 40.82 (40.44) 5.83 (5.52) 6.80 (6.45)
C14H24CuN2O8
(3) [Ni(L1)2(H2O)2] [406.7] 330–332 70 41.31 (41.65) 5.90 (5.98) 6.88 (6.57)
C14H24NiN2O8
(4) [Zn(L1)2(H2O)2] [411.4] 331–332 70 40.84 (40.63) 5.83 (5.62) 6.81 (6.96)
C14H24ZnN2O8
(5) [Co(L2)2(H2O)2] [586.9] 378–380 72 57.25 (57.53) 6.13 (6.55) 4.77 (4.63)
C28H36CoN2O8
(6) [Cu(L2)2(H2O)2] [563.5] 335–337 72 56.80 (56.66) 6.09 (6.37) 4.73 (4.58)
C28H36CuN2O8
(7) [Ni(L2)2(H2O)2] [586.7] 338–340 73 57.27 (57.14) 6.14 (6.47) 4.77 (4.84)
C28H36NiN2O8
(8) [Zn(L2)2(H2O)2] [591.4] 332–334 72 56.82 (56.98) 6.09 (5.84) 4.73 (4.65)
C28H36ZnN2O8
(9) [Co(L3)2(H2O)2] [490.9] 339–341 74 48.89 (48.73) 7.33 (7.62) 5.70 (5.53)
C20H36CoN2O8
(10) [Cu(L3)2(H2O)2] [495.5] 344–346 73 48.43 (48.87) 7.26 (7.18) 5.65 (5.85)
C20H36CuN2O8
(11) [Ni(L3)2(H2O)2] [490.7] 340–342 73 48.91 (48.76) 7.34 (7.58) 5.71 (5.43)
C20H36NiN2O8
(12) [Zn(L3)2(H2O)2] [495.4] 337–339 72 48.45 (48.63) 7.27 (7.47) 5.65 (5.96)
C20H36ZnN2O8
(13) [Co(L4)2(H2O)2] [566.9] 238–240 72 46.57 (46.66) 5.64 (5.53) 14.82 (14.72)
C22H32CoN6O8
(14) [Cu(L4)2(H2O)2] [571.5] 230–232 70 46.19 (46.54) 5.60 (5.43) 14.70 (14.57)
C22H32CuN6O8
(15) [Ni(L4)2(H2O)2] [566.7] 227–229 71 46.59 (46.62) 5.65 (5.57) 14.82 (14.66)
C22H32NiN6O8
(16) [Zn(L4)2(H2O)2] [571.4] 225–227 72 46.20 (46.06) 5.60 (5.81) 14.70 (14.98)
C22H32ZnN6O8
(17) [Co(L5)2(H2O)2] [434.9] 240–242 73 44.15 (44.48) 6.44 (6.16) 6.44 (6.82)
C16H28CoN2O8
(18) [Cu(L5)2(H2O)2] [439.5] 244–246 72 43.68 (43.36) 6.37 (6.56) 6.37 (6.73)
C16H28CuN2O8
(19) [Ni(L5)2(H2O)2] [434.7] 245–247 70 44.16 (44.44) 6.44 (6.38) 6.44 (6.16)
C16H28NiN2O8
(20) [Zn(L5)2(H2O)2] [439.4] 236–238 69 43.70 (43.34) 6.37 (6.15) 6.37 (6.62)
C16H28ZnN2O8
(21) [Co(L1)(H2O)4]Cl [322.4] 206–208 70 26.05 (26.37) 5.58 (5.41) 4.34 (4.13)
C7H18CoNO7Cl
(22) [Cu(L1)(H2O)4]Cl [327.0] 216–218 71 25.68 (25.44) 5.50 (5.82) 4.28 (4.45)
C7H18CuNO7Cl
(23) [Ni(L1)(H2O)4]Cl [322.2] 212–214 72 26.07 (26.38) 5.59 (5.88) 4.35 (4.54)
C7H18NiNO7Cl
(24) [Zn(L1)(H2O)4]Cl [326.9] 202–204 70 25.70 (25.53) 5.51 (5.62) 4.28 (4.11)
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Table 1: Continued.
Number Metal chelate MP (◦C) Yield (%) Calc (found) %
CHN
(25) [Co(L2)(H2O)4]Cl [412.4] 218–220 73 40.73 (40.93) 5.82 (5.55) 3.39 (3.18)
C14H24CoNO7Cl
(26) [Cu(L2)(H2O)4]Cl [417] 227–229 72 40.28 (40.46) 5.75 (5.64) 3.36 (3.67)
C14H24CuNO7Cl
(27) [Ni(L2)(H2O)4]Cl [412.2] 220–222 73 40.76 (40.43) 5.82 (5.64) 3.40 (3.13)
C14H24NiNO7Cl
(28) [Zn(L2)(H2O)4]Cl [416.9] 214–216 72 40.30 (40.48) 5.76 (5.40) 3.36 (3.58)
C14H24ZnNO7Cl
(29) [Co(L3)(H2O)4]Cl [364.4] 230–232 70 32.93 (32.67) 6.59 (6.35) 3.84 (3.53)
C10H24CoNO7Cl
(30) [Cu(L3)(H2O)4]Cl [369.0] 238–240 71 32.52 (32.84) 6.50 (6.18) 3.79 (3.88)
C10H24CuNO7Cl
(31) [Ni(L3)(H2O)4]Cl [364.2] 240–242 72 32.95 (33.28) 6.59 (6.34) 3.84 (3.63)
C10H24NiNO7Cl
(32) [Zn(L3)(H2O)4]Cl [368.9] 235–237 73 32.53 (32.43) 6.51 (6.87) 3.80 (3.96)
C10H24ZnNO7Cl
(33) [Co(L4)(H2O)4]Cl [402.4] 233–235 73 32.80 (32.66) 5.47 (5.53) 10.44 (10.72)
C11H22CoN3O7Cl
(34) [Cu(L4)(H2O)4]Cl [407.0] 235–237 74 32.43 (32.64) 5.40 (5.27) 10.32 (10.57)
C11H22CuN3O7Cl
(35) [Ni(L4)(H2O)4]Cl [402.2] 220–222 73 32.82 (32.58) 5.47 (5.65) 10.44 (10.68)
C11H22NiN3O7Cl
(36) [Zn(L4)(H2O)4]Cl [406.9] 238–240 72 32.44 (32.06) 5.41 (5.83) 10.32 (10.78)
C11H22ZnN3O7Cl
(37) [Co(L5)(H2O)4]Cl [336.4] 244–246 73 28.53 (28.68) 5.94 (5.64) 4.16 (4.52)
C8H20CoNO7Cl
(38) [Cu(L5)(H2O)4]Cl [341.0] 248–250 72 28.15 (28.36) 5.86 (5.56) 4.11 (4.43)
C8H20CuNO7Cl
(39) [Ni(L5)(H2O)4]Cl [336.2] 244–246 73 28.56 (28.74) 5.95 (5.78) 4.16 (4.56)
C8H20NiNO7Cl
(40) [Zn(L5)(H2O)4]Cl [340.9] 247–249 72 28.16 (28.48) 5.87 (5.65) 4.11 (4.42)
C8H20ZnNO7Cl
O O
CR
N
C
CH3
OH
CH3
OH2
M
OH2
N
CR
O O
C
H3C
CH3
OH
M = Co(II),Cu(II),Ni(II) or Zn(II)
(a)
H3C
C
OH2
OH2
M
OH2
OH2
O O
CR
N
CH3
OH
Cl
M = Co(II),Cu(II),Ni(II) or Zn(II)
(b)
Figure 2: Proposed structures of the metal(II) complexes (1)–(40).Zahid H. Chohan et al 7
Table 2: Physical and spectral data of the metal(II) complexes (1)–(40).
Number Color BM (μeﬀ)I R ( c m −1) λmax (cm−1)
(1) Dark brown 4.4
3444 (OH), 3020 (OH2),
17543, 21739, 29290 1610 (C=N), 1385 (C−O),
525 (M−O), 470 (M−N)
(2) Light blue 1.7
3450 (OH), 3025 (OH2),
15151, 30235 1620 (C=N), 1335 (C−O),
440 (M−N), 520 (M−O)
(3) Dull green 3.1
3445 (OH), 3015 (OH2),
12897, 16528,
24390, 30215 1615 (C=N), 1335 (C−O),
430 (M−N), 535 (M−O)
(4) Oﬀ-white Dia
3448 (OH), 3025 (OH2),
28445 1610 (C=N), 1335 (C−O),
435 (M−N), 545 (M−O)
(5) Dark brown 4.2
3444 (OH), 3025 (OH2),
18018, 22222, 29565 1615 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(6) Dark blue 1.7
3444 (OH), 3015 (OH2),
15873, 30380 1615 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(7) Dark green 3.1
3448 (OH), 3020 (OH2),
13333, 16667,
25000, 30365 1620 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(8) Cream Dia
3445 (OH), 3020 (OH2),
28680 1620 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(9) Brown 4.5
3448 (OH), 3025 (OH2),
17750, 21535, 29310 1610 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(10) Bluish green 1.8
3450 (OH), 3015 (OH2),
15470, 30355 1615 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(11) Dark green 3.3
3444 (OH), 3015 (OH2),
12975, 16585,
24685, 30310 1610 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(12) Pale yellow Dia
3450 (OH), 3020 (OH2),
28525 1615 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(13) Tea pink 4.3
3445 (OH), 3015 (OH2),
17850, 21950, 29410 1610 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(14) Green 1.9
3448 (OH), 3025 (OH2),
15510, 30290 1615 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(15) Sea green 3.2
3445 (OH), 3025 (OH2),
13230, 16660,
24880, 30360 1620 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)8 Bioinorganic Chemistry and Applications
Table 2: Continued.
Number Color BM (μeﬀ)I R ( c m −1) λmax (cm−1)
(16) Oﬀ-white Dia
3444 (OH), 3020 (OH2),
30360 1615 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(17) Dark brown 4.5
3450 (OH), 3015 (OH2),
17985, 22125, 29490 1620 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(18) Blue 1.8
3450 (OH), 3020 (OH2),
15750, 30360 1620 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(19) Dark green 3.4
3444 (OH), 3020 (OH2),
13215, 16575,
24910, 30355 1610 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(20) Cream Dia
3445 (OH), 3020 (OH2),
28610 1620 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(21) Dark blue 4.2
3450 (OH), 3025 (OH2),
18010, 21745, 29290 1615 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(22) Green 1.7
3450 (OH), 3015 (OH2),
15545, 30235 1610 (C=N), 1335 (C−O),
440 (M−N), 520 (M−O)
(23) Dirty green 3.1
3450 (OH), 3015 (OH2),
12897, 16580,
24490, 30215 1615 (C=N), 1335 (C−O),
430 (M−N), 535 (M−O)
(24) Oﬀ-white Dia
3450 (OH), 3025 (OH2),
28445 1620 (C=N), 1335 (C−O),
435 (M−N), 545 (M−O)
(25) Dark blue 4.4
3448 (OH), 3020 (OH2),
17500, 22124, 29565 1615 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(26) Dirty green 1.7
3450 (OH), 3025 (OH2),
15795, 30380 1615 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(27) Sea green 3.1
3448 (OH), 3015 (OH2),
13233, 16590,
25000, 30365 1615 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(28) Pale yellow Dia
3450 (OH), 3020 (OH2),
28680 1620 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(29) Royal blue 4.5
3450 (OH), 3025 (OH2),
17750, 21995, 29310 1610 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(30) Green 1.8
3448 (OH), 3015 (OH2),
15490, 30355 1620 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)Zahid H. Chohan et al 9
Table 2: Continued.
Number Color BM (μeﬀ)I R ( c m −1) λmax (cm−1)
(31) Dull green 3.3
3448 (OH), 3020 (OH2),
12995, 16655,
24685, 30310 1620 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(32) Yellow Dia
3450 (OH), 3025 (OH2),
28525 1615 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(33) Purple blue 4.3
3450 (OH), 3025 (OH2),
17855, 21925, 29410 1610 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(34) Bluish green 1.9
3448 (OH), 3015 (OH2),
15515, 30290 1620 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(35) Dirty green 3.2
3450 (OH), 3020 (OH2),
13130, 16565,
24880, 30360 1620 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(36) Pale yellow Dia
3450 (OH), 3025 (OH2),
30360 1615 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(37) Dark brown 4.5
3448 (OH), 3015 (OH2),
17985, 22125, 29490 1615 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(38) Green 1.8
3450 (OH), 3020 (OH2),
15750, 30360 1620 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(39) Light green 3.4
3448 (OH), 3020 (OH2),
13215, 16570,
24910, 30355 1610 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
(40) Cream Dia
3450 (OH), 3015 (OH2),
28610 1620 (C=N), 1335 (C−O),
425 (M−O), 390 (M−N)
this position typically is expected for an octahedral con-
ﬁguration and may be assigned to 10Dq corresponding
to the transition 2Eg→2T2g [49]. The strong high-energy
band, in turn, is assigned to metal → ligand charge trans-
fer. Also, the magnetic moment values (1.9–2.2BM) for the
copper(II) are indicative of antiferromagnetic spin-spin in-
teraction through molecular association. Hence, the cop-
per(II) complexes appear to be in the octahedral geometry
with d
2
x–d
2
y ground state [51]. The electronic spectra of the
Ni(II) complexes showed d-d bands in the regions 24390–
25000, 16528–16667, and 12987–13333cm−1. These are as-
signed to the spin-allowed transitions 3A2g(F)→3T2g(F),
3A2g(F)→3T1g(F), and 3A2g(F)→3T1g(P), respectively, consis-
tent with their well-deﬁned octahedral conﬁguration. The
band at 29815–30335cm−1 was assigned to metal → ligand
charge transfer. The magnetic measurements (3.0–3.3BM)
showedtwounpairedelectronsperNi(II)ionsuggesting[52]
also an octahedral geometry for the Ni(II) complexes. The
electronic spectra of the Zn(II) complexes exhibited only a
high-intensity band at 28 350–29 145cm−1 and are assigned
[49] to a ligand-metal charge transfer.
Biologicalactivity
The antibacterial activity results presented in Table 3 show
that the newly synthesized compounds (L1)–(L5) and their
metal(II) complexes (1)–(40) possess biological activity.
These new derivatives obtained by condensation of the
amino group of amino acid with salicylaldehyde were
screenedfortheirantibacterialactivityagainstEcoli,Bsubtil-
lis, S ﬂexenari, S aureus, P aeruginosa, and S typhi and for an-
tifungal activity (Table 4) against T longifusus, C albicans, A
ﬂavus, M canis, F solani,a n dCgl a b er a t a . These results exhib-
ited markedly an enhancement in activity on coordination10 Bioinorganic Chemistry and Applications
Table 3: Results of antibacterial bioassay (concentration used
1mg/mL of DMSO). (a) Ec o l i ,( b )Sﬂ e x e n a r i ,( c )P aeruginosa,( d )
St y p h i ,( e )S aureus,( f)B subtilis 10 <: weak; > 10: moderate; > 16:
signiﬁcant.
Bacteria
Gram-negative Gram-positive
(a) (b) (c) (d) (e) (f)
C
o
m
p
o
u
n
d
(
z
o
n
e
o
f
i
n
h
i
b
i
t
i
o
n
)
L1 12 07 13 11 16 15
L2 14 07 14 14 15 16
L3 14 08 12 15 16 17
L4 13 05 14 14 17 14
L5 12 07 15 15 17 15
1 16 10 16 16 18 17
2 15 11 15 17 18 18
3 15 10 17 18 18 18
4 16 12 22 18 19 19
5 15 10 17 18 19 18
6 15 10 16 17 19 17
7 16 11 17 18 20 18
8 16 11 18 19 21 19
9 17 10 17 17 18 18
10 16 10 18 16 19 19
11 17 11 16 17 19 18
12 19 12 17 24 20 19
13 16 10 16 19 19 18
14 16 11 17 17 17 18
15 17 10 18 18 18 17
16 18 11 17 20 20 20
17 14 09 17 17 18 18
18 17 10 18 18 19 19
19 19 09 16 18 19 19
20 25 10 19 18 20 21
21 12 07 13 12 15 17
22 11 06 14 13 16 18
23 12 06 12 12 17 16
24 15 09 16 14 18 24
25 12 08 14 13 16 16
26 12 07 15 12 15 17
27 14 08 14 12 17 19
28 15 09 16 14 18 19
29 11 08 12 12 14 15
30 12 07 12 11 16 16
31 13 07 14 13 15 16
32 14 10 15 15 17 18
33 13 08 14 14 16 17
34 14 09 13 15 15 16
35 12 07 14 15 16 17
36 14 11 16 17 17 18
37 11 09 15 14 15 18
38 12 08 15 15 16 16
39 13 09 14 16 17 17
40 15 10 16 17 26 19
∗SD 30 27 26 27 30 28
∗SD: standard drug (Imipenem).
Table 4: Results of antifungal bioassay (concentration used
200μg/mL). (a) T longifucus,( b )C albicans,( c )Aﬂ a v u s ,( d )Mc a -
nis,( e )Fs o l a n i ,( f)Cg l a b e r a t a .
Organism
(a) (b) (c) (d) (e) (f)
C
o
m
p
o
u
n
d
(
z
o
n
e
o
f
i
n
h
i
b
i
t
i
o
n
)
L1 16 00 15 10 00 18
L2 00 07 00 00 15 00
L3 17 00 00 00 00 00
L4 20 00 00 15 00 20
L5 00 00 00 00 00 00
1 17 00 18 15 00 20
2 18 00 20 14 00 18
3 20 00 19 12 00 19
4 22 00 20 21 00 22
5 00 10 00 00 17 00
6 10 17 00 00 18 17
7 00 15 00 00 18 00
8 00 18 00 00 20 00
9 19 00 00 00 00 00
10 20 00 17 00 00 00
11 22 00 00 00 00 00
12 24 00 00 00 00 00
13 22 00 00 00 00 00
14 24 20 00 25 20 20
15 23 00 00 00 00 00
16 25 00 18 30 00 00
17 00 00 00 00 00 00
18 00 00 00 00 00 00
19 00 00 00 00 00 00
20 00 00 00 00 00 00
21 00 00 00 19 00 00
22 00 00 00 00 00 00
23 00 18 00 00 00 00
24 20 00 00 00 24 18
25 00 17 17 17 17 00
26 00 00 15 00 00 17
27 00 00 00 00 15 00
28 00 00 00 00 00 00
29 00 00 00 00 00 00
30 00 00 00 00 00 00
31 00 00 00 00 00 00
32 00 20 00 19 00 00
33 00 20 20 20 20 20
34 00 00 00 00 00 20
35 00 00 19 00 00 00
36 00 00 00 00 00 00
37 00 00 00 00 00 00
38 00 00 00 00 00 00
39 00 00 00 00 00 00
40 00 00 19 00 00 20
∗SD ABCDEF
∗SD = standard drugs MIC μg/mL; A = Miconazole (70μg/mL: 1.6822
×10−7 M), B = Miconazole (110.8μg/mL: 2.6626 ×10−7 M), C = Am-
photericin B (20μg/mL: 2.1642×10−8 M), D=Miconazole (98.4μg/mL:
2.3647 ×10−7 M), E = Miconazole (73.25μg/mL: 1.7603 ×10−7 M), F =
Miconazole (110.8μg/mL: 2.66266 ×10−7 M).Zahid H. Chohan et al 11
Table 5: Results of minimum inhibitory concentration (M/mL) of the selected compounds (4), (12), (20), (24), and (40) against selected
bacteria.
N u m b e r 4 1 22 02 44 0
Gram-negative
Ec o l i —— 5 .690 ×10−8 ——
P aeruginosa 1.215 ×10−7 ————
St y p h i —5 .046 ×10−8 ———
Gram-positive
S aureus ———— 2 .933 ×10−8
B subtilis ——— 7 .648 ×10−8 —
Table 6: Brine shrimp bioassay data of the ligands (L1)–(L5)a n d
their metal(II) complexes (1)–(40).
Compound LD50 (M/mL)
L1 6.369 ×10−3
L2 4.292 ×10−3
L3 5.025 ×10−3
L4 4.484 ×10−3
L5 5.848 ×10−3
12 .458 ×10−3
22 .430 ×10−3
38 .975 ×10−4
42 .431 ×10−3
51 .704 ×10−3
61 .691 ×10−3
77 .022 ×10−4
81 .691 ×10−3
92 .037 ×10−3
10 8.839 ×10−4
11 7.133 ×10−4
12 2.018 ×10−3
13 1.764 ×10−3
14 1.750 ×10−3
15 1.765 ×10−3
16 1.750 ×10−3
17 2.299 ×10−3
18 2.275 ×10−3
19 2.300 ×10−3
20 2.276 ×10−3
21 3.102 ×10−3
22 9.725 ×10−4
23 3.104 ×10−3
24 3.059 ×10−3
25 2.425 ×10−3
26 2.398 ×10−3
27 2.426 ×10−3
28 2.399 ×10−3
29 2.744 ×10−3
30 2.710 ×10−3
31 1.112 ×10−3
32 2.711 ×10−3
33 2.485 ×10−3
34 2.457 ×10−3
35 2.486 ×10−3
36 2.458 ×10−3
37 2.973 ×10−3
38 1.246 ×10−3
39 2.974 ×10−3
40 2.933 ×10−3
with the metal ions against one or more testing bacterial
strains. This enhancement in the activity is rationalized on
the basis of the structures of, (L1)–(L5) by possessing an ad-
ditional azomethine (C=N) linkage which imports in eluci-
dating the mechanism of transamination and resamination
reactions in biological system [53, 54]. It has also been sug-
gested [55–65] that the ligands with nitrogen and oxygen
donor systems might inhibit enzyme production, since the
enzymes which require these groups for their activity appear
to be especially more susceptible to deactivation by the metal
ions upon chelation. Chelation reduces the polarity [55–65]
of the metal ion mainly because of the partial sharing of its
positive charge with the donor groups and possibly the π-
electron delocalization within the whole chelate ring system
thus formed during coordination. This process of chelation
thusincreasesthelipophilicnatureofthecentralmetalatom,
which in turn favors its permeation through the lipoid layer
of the membrane. This in turn is responsible for increasing
the hydrophobic character and liposolubility of the molecule
in crossing cell membrane of the microorganism, and hence
enhances the biological utilization ratio and activity of the
testing drug/compound.
Cytotoxicbioassay
All the synthesized compounds were screened for their cyto-
toxicity (brine shrimp bioassay) using the protocol of Meyer
etal [66].FromthedatarecordedinTable 6,itisevidentthat
only ﬁve compounds (3), (7), (10), (11), and (22) displayed
potent cytotoxic activity as LD50 = 8.974 ×10−4,7 .022 ×
10−4,8 .839×10−4,7 .133×10−4,a n d9 .725×10−4 M/mL, re-
spectively, against Artemia salina while all other compounds
were almost inactive for this assay.
CONCLUSION
The synthesized amino acid-derived compounds showed an-
tibacterial/antifungal properties. In comparison, the cobalt
(II), copper(II), nickel(II), and zinc(II) metal complexes of
these compounds showed more activity against one or more
bacterial/fungal strains, thus introducing a novel class of
metal-based bactericidal and fungicidal agents.
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